secwatch.observer — SEC 8-K summary
======================================

Issuer:     Journey Medical Corp (DERM)
CIK:        0001867066
Form:       8-K
Filed at:   2025-08-28T23:59:59+00:00
Accession:  0001104659-25-084879
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Journey Medical signs new ATM agreement to sell up to 3.75M common shares, ends prior B. Riley facility
--------------------------------------------------------------------------------

- New Sales Agreement with B. Riley and Lake Street allows sale of up to 3,750,000 shares of common stock at the market.
- Agents will receive a commission of 3.0% of gross proceeds from sales under the new agreement.
- Prior Sales Agreement with B. Riley terminated effective August 28, 2025; 4,121,318 shares sold under it since December 2022.
- Company is not obligated to make any sales; offering terminates upon sale of all shares or agreement termination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1867066/000110465925084879/0001104659-25-084879-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1867066/000110465925084879/tm2524202d2_8kseq1.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-084879

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer